Immunocore Holdings plc (FRA:6YG)
Germany · Delayed Price · Currency is EUR 31.40
0.00 (0.00%)
At close: Aug 26, 2026
Immunocore Holdings Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -18.07 | -35.51 | -51.09 | -55.29 | -52.54 | -180.03 |
Depreciation & Amortization | 3.61 | 3.27 | 4.2 | 4.09 | 5.34 | 7.59 |
Loss (Gain) From Sale of Investments | -14.41 | -19.73 | -14.58 | - | - | - |
Stock-Based Compensation | 33.88 | 37.7 | 34.19 | 32.47 | 32.89 | 48.89 |
Other Operating Activities | 10.95 | 12.87 | 4.38 | 10.04 | -10.72 | 2.4 |
Change in Accounts Receivable | -26.55 | -7.34 | -12.35 | -17.87 | -26.26 | -4.86 |
Change in Accounts Payable | 2.3 | -2.46 | 7.27 | 2.63 | 4.91 | 1.47 |
Change in Unearned Revenue | -0.58 | -0.39 | -0 | -8.01 | -25.5 | -29.07 |
Change in Other Net Operating Assets | -26.08 | 0.88 | 54.03 | 34.88 | 22.69 | 10.5 |
Operating Cash Flow | -34.96 | -10.71 | 26.06 | 2.94 | -49.21 | -143.11 |
Operating Cash Flow Growth | - | - | 786.43% | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -6.2 | -4.34 | -5.17 | -5.43 | -2.2 | -1.39 |
Sale of Property, Plant & Equipment | - | - | 0.04 | - | 0.01 | 0.11 |
Investment in Securities | 14 | -12 | -350 | - | - | - |
Investing Cash Flow | 7.81 | -16.34 | -355.13 | -5.43 | -2.2 | -1.28 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | 402.5 | - | 50 | - |
Long-Term Debt Repaid | - | - | -52.06 | - | -52 | - |
Net Debt Issued (Repaid) | - | - | 350.44 | - | -2 | - |
Issuance of Common Stock | 23.29 | 12.37 | 6.8 | 34.35 | 149.21 | 288.19 |
Other Financing Activities | - | - | -13.36 | - | -1.77 | - |
Financing Cash Flow | 23.29 | 12.37 | 343.88 | 34.35 | 145.44 | 288.19 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.85 | 26.66 | -1.71 | 8.29 | -12.65 | 0.63 |
Net Cash Flow | -3.01 | 11.98 | 13.11 | 40.15 | 81.39 | 144.42 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -41.15 | -15.05 | 20.89 | -2.49 | -51.41 | -144.49 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -9.55% | -3.76% | 6.73% | -1.00% | -29.49% | -396.04% |
Free Cash Flow Per Share | -0.81 | -0.30 | 0.42 | -0.05 | -1.13 | -3.40 |
Levered Free Cash Flow | 35.59 | 23.96 | 38.39 | 14.06 | -19.73 | -50.31 |
Unlevered Free Cash Flow | 43.22 | 31.56 | 50.17 | 17.28 | -16.35 | -46.83 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | 3.89 | 4.64 | 0.51 | 0.98 | 0.77 | -17.04 |
Change in Working Capital | -50.9 | -9.3 | 48.95 | 11.63 | -24.17 | -21.96 |